| Year |
Citation |
Score |
| 2024 |
Karginov TA, Ménoret A, Leclair NK, Harrison AG, Chandiran K, Suarez-Ramirez JE, Yurieva M, Karlinsey K, Wang P, O'Neill RJ, Murphy PA, Adler AJ, Cauley LS, Anczuków O, Zhou B, ... Vella AT, et al. Autoregulated splicing of β programs T cell fate in response to antigen-receptor stimulation. Science (New York, N.Y.). 385: eadj1979. PMID 39265028 DOI: 10.1126/science.adj1979 |
0.312 |
|
| 2024 |
Pulikkot S, Paul S, Hall A, Gardner B, Liu W, Hu L, Vella AT, Chen Y, Fan Z. Monitoring Circulating Myeloid Cells in Peritonitis with an In Vivo Imaging Flow Cytometer. Biomolecules. 14. PMID 39199274 DOI: 10.3390/biom14080886 |
0.326 |
|
| 2024 |
Nicholas SE, Helming SR, Ménoret A, Pathoulas C, Xu MM, Hensel J, Kimble AL, Heineman B, Jellison ER, Reese B, Zhou B, Rodriguez-Oquendo A, Vella AT, Murphy PA. Endothelial Immunosuppression in Atherosclerosis : Translational Control by Elavl1/HuR. Biorxiv : the Preprint Server For Biology. PMID 39131295 DOI: 10.1101/2024.08.02.605922 |
0.442 |
|
| 2023 |
Sutter PA, Ménoret A, Jellison ER, Nicaise AM, Bradbury AM, Vella AT, Bongarzone ER, Crocker SJ. CD8+ T cell depletion prevents neuropathology in a mouse model of globoid cell leukodystrophy. The Journal of Experimental Medicine. 220. PMID 37310382 DOI: 10.1084/jem.20221862 |
0.333 |
|
| 2023 |
Ménoret A, Agliano F, Karginov TA, Karlinsey KS, Zhou B, Vella AT. Antigen-specific downregulation of miR-150 in CD4 T cells promotes cell survival. Frontiers in Immunology. 14: 1102403. PMID 36817480 DOI: 10.3389/fimmu.2023.1102403 |
0.335 |
|
| 2022 |
Karginov TA, Ménoret A, Vella AT. Optimal CD8 T cell effector function requires costimulation-induced RNA-binding proteins that reprogram the transcript isoform landscape. Nature Communications. 13: 3540. PMID 35725727 DOI: 10.1038/s41467-022-31228-0 |
0.376 |
|
| 2022 |
Agliano F, Ménoret A, Vella AT. Evaluating the glycolytic potential of mouse costimulated effector CD8 T cells . Star Protocols. 3: 101441. PMID 35677608 DOI: 10.1016/j.xpro.2022.101441 |
0.365 |
|
| 2022 |
Agliano F, Karginov TA, Ménoret A, Provatas A, Vella AT. Nicotinamide breaks effector CD8 T cell responses by targeting mTOR signaling. Iscience. 25: 103932. PMID 35243268 DOI: 10.1016/j.isci.2022.103932 |
0.401 |
|
| 2022 |
Li C, Phoon YP, Karlinsey K, Tian YF, Thapaliya S, Thongkum A, Qu L, Matz AJ, Cameron M, Cameron C, Menoret A, Funchain P, Song JM, Diaz-Montero CM, Tamilselvan B, ... ... Vella A, et al. A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients. The Journal of Experimental Medicine. 219. PMID 34807232 DOI: 10.1084/jem.20202084 |
0.348 |
|
| 2020 |
Agliano F, Karlinsey KS, Ragazzi M, Ménoret A, Vella AT. A benzimidazole inhibitor attenuates sterile inflammation induced in a model of systemic autoinflammation in female mice Scientific Reports. 10: 12100. PMID 32694575 DOI: 10.1038/S41598-020-68985-1 |
0.339 |
|
| 2020 |
Li C, Phoon YP, Karlinsey K, Tian Y, Thapaliya S, Qu L, Cameron M, Cameron C, Menoret A, Funchain P, Song J, Marcela Diaz-Montero C, Rodriguez A, Bonin C, Vella A, et al. P853 Single cell transcriptome analysis identifies unique features in circulating CD8+ T cells that can predict immunotherapy response in melanoma patients Journal For Immunotherapy of Cancer. 8: A5.1-A5. DOI: 10.1136/Lba2019.7 |
0.429 |
|
| 2019 |
Chen J, Ye X, Pitmon E, Lu M, Wan J, Jellison ER, Adler AJ, Vella AT, Wang K. IL-17 inhibits CXCL9/10-mediated recruitment of CD8 cytotoxic T cells and regulatory T cells to colorectal tumors. Journal For Immunotherapy of Cancer. 7: 324. PMID 31775909 DOI: 10.1186/S40425-019-0757-Z |
0.402 |
|
| 2019 |
Konstorum A, Vella AT, Adler AJ, Laubenbacher RC. A mathematical model of combined CD8 T cell costimulation by 4-1BB (CD137) and OX40 (CD134) receptors. Scientific Reports. 9: 10862. PMID 31350431 DOI: 10.1038/S41598-019-47333-Y |
0.463 |
|
| 2019 |
Willis CM, Nicaise AM, Menoret A, Ryu JK, Mendiola AS, Jellison ER, Givogri MI, Han DK, Bongarzone ER, Akassoglou K, Vella AT, Crocker SJ. Extracellular vesicle fibrinogen induces encephalitogenic CD8+ T cells in a mouse model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 31068461 DOI: 10.1073/Pnas.1816911116 |
0.439 |
|
| 2019 |
Morales Del Valle C, Maxwell JR, Xu MM, Menoret A, Mittal P, Tsurutani N, Adler AJ, Vella AT. Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism. Cell Reports. 27: 1434-1445.e3. PMID 31042471 DOI: 10.1016/J.Celrep.2019.04.016 |
0.463 |
|
| 2019 |
Li C, Menoret A, Farragher C, Ouyang Z, Bonin C, Holvoet P, Vella AT, Zhou B. Single cell transcriptomics based-MacSpectrum reveals novel macrophage activation signatures in diseases. Jci Insight. 5. PMID 30990466 DOI: 10.1172/Jci.Insight.126453 |
0.305 |
|
| 2019 |
Xu MM, Ménoret A, Nicholas SE, Günther S, Sundberg EJ, Zhou B, Rodriguez A, Murphy PA, Vella AT. Direct CD137 costimulation of CD8 T cells promotes retention and innate-like function within nascent atherogenic foci. American Journal of Physiology. Heart and Circulatory Physiology. PMID 30978132 DOI: 10.1152/Ajpheart.00088.2019 |
0.488 |
|
| 2019 |
Xu MM, Murphy PA, Vella AT. Activated T effector seeds: Cultivating atherosclerotic plaque through alternative activation. American Journal of Physiology. Heart and Circulatory Physiology. PMID 30925075 DOI: 10.1152/Ajpheart.00148.2019 |
0.483 |
|
| 2018 |
Shinde P, Bharat V, Rodriguez-Oquendo A, Zhou B, Vella AT. Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses. Expert Opinion On Biological Therapy. PMID 30169979 DOI: 10.1080/14712598.2018.1518422 |
0.415 |
|
| 2018 |
Ménoret A, Buturla JA, Xu MM, Svedova J, Kumar S, Rathinam VAK, Vella AT. T cell-directed IL-17 production by lung granular γδ T cells is coordinated by a novel IL-2 and IL-1β circuit. Mucosal Immunology. PMID 29907868 DOI: 10.1038/S41385-018-0037-0 |
0.336 |
|
| 2018 |
Ryan JM, Mittal P, Menoret A, Svedova J, Wasser JS, Adler AJ, Vella AT. A novel biologic platform elicits profound T cell costimulatory activity and antitumor immunity in mice. Cancer Immunology, Immunotherapy : Cii. PMID 29327109 DOI: 10.1007/S00262-018-2116-1 |
0.457 |
|
| 2018 |
Mittal P, Abblett R, Ryan JM, Hagymasi AT, Agyekum-Yamoah A, Svedova J, Reiner SL, St Rose MC, Hanley MP, Vella AT, Adler AJ. An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 29305435 DOI: 10.4049/Jimmunol.1701039 |
0.452 |
|
| 2017 |
Li C, Xu MM, Wang K, Adler AJ, Vella AT, Zhou B. Macrophage polarization and meta-inflammation. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 29154757 DOI: 10.1016/J.Trsl.2017.10.004 |
0.306 |
|
| 2017 |
Granados HM, Draghi A, Tsurutani N, Wright K, Fernandez ML, Sylvester FA, Vella AT. Programmed cell death-1, PD-1, is dysregulated in T cells from children with new onset type 1 diabetes. Plos One. 12: e0183887. PMID 28877189 DOI: 10.1371/Journal.Pone.0183887 |
0.35 |
|
| 2017 |
Li C, Ying W, Huang Z, Brehm T, Morin A, Vella AT, Zhou B. IRF6 regulates alternative activation by suppressing PPARγ in male murine macrophages. Endocrinology. PMID 28645193 DOI: 10.1210/En.2017-00053 |
0.304 |
|
| 2017 |
Svedova J, Ménoret A, Mittal P, Ryan JM, Buturla JA, Vella AT. Therapeutic blockade of CD54 attenuates pulmonary barrier damage in T cell-induced acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology. ajplung.00050.2017. PMID 28473322 DOI: 10.1152/Ajplung.00050.2017 |
0.465 |
|
| 2017 |
Shinde P, Liu W, Ménoret A, Luster AD, Vella AT. Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production. Journal of Leukocyte Biology. PMID 28432083 DOI: 10.1189/Jlb.1A0616-261Rr |
0.518 |
|
| 2017 |
Adler AJ, Mittal P, Ryan JM, Zhou B, Wasser JS, Vella AT. Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy. Immunotherapy. 9: 71-82. PMID 28000531 DOI: 10.2217/Imt-2016-0097 |
0.394 |
|
| 2016 |
Wang K, Vella AT. Regulatory T Cells and Cancer: A Two-Sided Story. Immunological Investigations. 1-16. PMID 27603750 DOI: 10.1080/08820139.2016.1197242 |
0.426 |
|
| 2016 |
Sayej WN, Ménoret A, Maharjan AS, Fernandez M, Wang Z, Balarezo F, Hyams JS, Sylvester FA, Vella AT. Characterizing the inflammatory response in esophageal mucosal biopsies in children with eosinophilic esophagitis. Clinical & Translational Immunology. 5: e88. PMID 27525061 DOI: 10.1038/Cti.2016.30 |
0.477 |
|
| 2016 |
Svedova J, Tsurutani N, Liu W, Khanna KM, Vella AT. TNF and CD28 Signaling Play Unique but Complementary Roles in the Systemic Recruitment of Innate Immune Cells after Staphylococcus aureus Enterotoxin A Inhalation. Journal of Immunology (Baltimore, Md. : 1950). PMID 27183621 DOI: 10.4049/Jimmunol.1600113 |
0.475 |
|
| 2015 |
Tsurutani N, Mittal P, St Rose MC, Ngoi SM, Svedova J, Menoret A, Treadway FB, Laubenbacher R, Suárez-Ramírez JE, Cauley LS, Adler AJ, Vella AT. Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis. Journal of Immunology (Baltimore, Md. : 1950). PMID 26573834 DOI: 10.4049/Jimmunol.1501217 |
0.41 |
|
| 2015 |
Mittal P, St Rose MC, Wang X, Ryan JM, Wasser JS, Vella AT, Adler AJ. Tumor-Unrelated CD4 T Cell Help Augments CD134 Plus CD137 Dual Costimulation Tumor Therapy. Journal of Immunology (Baltimore, Md. : 1950). PMID 26561553 DOI: 10.4049/Jimmunol.1502032 |
0.46 |
|
| 2015 |
Ménoret A, Svedova J, Behl B, Vella AT. Trace Levels of Staphylococcal Enterotoxin Bioactivity Are Concealed in a Mucosal Niche during Pulmonary Inflammation. Plos One. 10: e0141548. PMID 26509442 DOI: 10.1371/Journal.Pone.0141548 |
0.429 |
|
| 2015 |
Liu W, Menoret A, Vella AT. Responses to LPS boost effector CD8 T-cell accumulation outside of signals 1 and 2. Cellular & Molecular Immunology. PMID 26189366 DOI: 10.1038/Cmi.2015.69 |
0.518 |
|
| 2015 |
Montrose DC, Nakanishi M, Murphy RC, Zarini S, McAleer JP, Vella AT, Rosenberg DW. The role of PGE2 in intestinal inflammation and tumorigenesis. Prostaglandins & Other Lipid Mediators. 116: 26-36. PMID 25460828 DOI: 10.1016/J.Prostaglandins.2014.10.002 |
0.301 |
|
| 2014 |
Wright KT, Giardina C, Vella AT. Therapeutic targeting of the inflammome. Biochemical Pharmacology. 92: 184-91. PMID 25204592 DOI: 10.1016/J.Bcp.2014.08.027 |
0.346 |
|
| 2014 |
Sylvester FA, Draghi A, Menoret A, Fernandez ML, Wang Z, Vella AT. Distinctive colonic mucosal cytokine signature in new-onset, untreated pediatric Crohn disease. Journal of Pediatric Gastroenterology and Nutrition. 59: 553-61. PMID 25000355 DOI: 10.1097/Mpg.0000000000000480 |
0.445 |
|
| 2014 |
Ménoret A, Drew DA, Miyamoto S, Nakanishi M, Vella AT, Rosenberg DW. Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells. Molecular Carcinogenesis. 53: E11-22. PMID 23255428 DOI: 10.1002/Mc.21986 |
0.311 |
|
| 2014 |
Ramanarasimhaiah R, Fernandez ML, Vella A, Sylvester FA. Sa1737 Osteoprotegerin: A Novel Alarmin in Colonic Epithelial Cells? Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)61008-8 |
0.331 |
|
| 2014 |
Granados H, Draghi A, Vella A, Sylvester FA. Sa1158 Increased Serum Lipopolysaccharide in Crohn's Disease Is Associated With Alterations in Toll-Like Receptor Expression in Peripheral Blood Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)60762-9 |
0.303 |
|
| 2014 |
Granados H, Draghi A, Sylvester FA, Vella A. Sa1157 Normal Programmed Death-1 Expression in Peripheral Blood T-Cells, but Not Monocytes in Children With New Onset Crohn Disease Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)60761-7 |
0.319 |
|
| 2013 |
Adler AJ, Vella AT. Striving for synergy: how to improve cancer immunotherapy through multiple agonist costimulation. Immunotherapy. 5: 1271-3. PMID 24283834 DOI: 10.2217/Imt.13.129 |
0.323 |
|
| 2013 |
Wright KT, Vella AT. RKIP contributes to IFN-γ synthesis by CD8+ T cells after serial TCR triggering in systemic inflammatory response syndrome. Journal of Immunology (Baltimore, Md. : 1950). 191: 708-16. PMID 23761631 DOI: 10.4049/Jimmunol.1203486 |
0.515 |
|
| 2013 |
Adler AJ, Vella AT. Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation. Oncoimmunology. 2: e22837. PMID 23482891 DOI: 10.4161/Onci.22837 |
0.473 |
|
| 2013 |
Kumar S, Colpitts SL, Ménoret A, Budelsky AL, Lefrancois L, Vella AT. Rapid αβ T-cell responses orchestrate innate immunity in response to Staphylococcal enterotoxin A Mucosal Immunology. 6: 1006-1015. PMID 23321986 DOI: 10.1038/Mi.2012.138 |
0.447 |
|
| 2013 |
St Rose MC, Taylor RA, Bandyopadhyay S, Qui HZ, Hagymasi AT, Vella AT, Adler AJ. CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion. Immunology and Cell Biology. 91: 173-83. PMID 23295363 DOI: 10.1038/Icb.2012.74 |
0.452 |
|
| 2013 |
Sylvester FA, Draghi A, Menoret A, Fernandez ML, Vella AT. Tu1948 Innate Immune Cytokines Characterize Colonic Inflammation in Newly Diagnosed Inflammatory Bowel Disease Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)63304-1 |
0.322 |
|
| 2012 |
Tewalt EF, Cohen JN, Rouhani SJ, Guidi CJ, Qiao H, Fahl SP, Conaway MR, Bender TP, Tung KS, Vella AT, Adler AJ, Chen L, Engelhard VH. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood. 120: 4772-82. PMID 22993390 DOI: 10.1182/Blood-2012-04-427013 |
0.457 |
|
| 2012 |
Ngoi SM, St Rose MC, Menoret AM, Smith DE, Tovey MG, Adler AJ, Vella AT. Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness. Proceedings of the National Academy of Sciences of the United States of America. 109: 10486-91. PMID 22689946 DOI: 10.1073/Pnas.1202607109 |
0.489 |
|
| 2012 |
Kuratnik A, Senapati VE, Verma R, Mellone BG, Vella AT, Giardina C. Acute sensitization of colon cancer cells to inflammatory cytokines by prophase arrest. Biochemical Pharmacology. 83: 1217-28. PMID 22306067 DOI: 10.1016/J.Bcp.2012.01.024 |
0.345 |
|
| 2012 |
Sylvester FA, Draghi A, Bausero MA, Fernandez ML, Vella AT. 1149 Osteoprotegerin Expression is Upregulated in the Colon of Children With Active Inflammatory Bowel Disease Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)60782-3 |
0.308 |
|
| 2012 |
Sylvester FA, Draghi A, Bausero MA, Wright K, Menoret A, Vella AT. 191 The Immunophenotype of the Colonic Mucosa in Children With IBD in “Deep Remission”: Healed is Distinct From Healthy Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)60180-2 |
0.301 |
|
| 2011 |
Qui HZ, Hagymasi AT, Bandyopadhyay S, St Rose MC, Ramanarasimhaiah R, Ménoret A, Mittler RS, Gordon SM, Reiner SL, Vella AT, Adler AJ. CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation. Journal of Immunology (Baltimore, Md. : 1950). 187: 3555-64. PMID 21880986 DOI: 10.4049/Jimmunol.1101244 |
0.462 |
|
| 2011 |
Blair DA, Turner DL, Bose TO, Pham QM, Bouchard KR, Williams KJ, McAleer JP, Cauley LS, Vella AT, Lefrançois L. Duration of antigen availability influences the expansion and memory differentiation of T cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 2310-21. PMID 21775679 DOI: 10.4049/Jimmunol.1100363 |
0.484 |
|
| 2011 |
Nakanishi M, Menoret A, Tanaka T, Miyamoto S, Montrose DC, Vella AT, Rosenberg DW. Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity. Cancer Prevention Research (Philadelphia, Pa.). 4: 1198-208. PMID 21576350 DOI: 10.1158/1940-6207.Capr-11-0188 |
0.353 |
|
| 2011 |
McAleer JP, Saris CJ, Vella AT. The WSX-1 pathway restrains intestinal T-cell immunity. International Immunology. 23: 129-37. PMID 21233255 DOI: 10.1093/Intimm/Dxq464 |
0.406 |
|
| 2010 |
Kumar S, Ménoret A, Ngoi SM, Vella AT. The systemic and pulmonary immune response to staphylococcal enterotoxins. Toxins. 2: 1898-912. PMID 22069664 DOI: 10.3390/Toxins2071898 |
0.347 |
|
| 2010 |
McAleer JP, Vella AT. Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide. Trends in Immunology. 31: 429-35. PMID 20880743 DOI: 10.1016/J.It.2010.08.005 |
0.488 |
|
| 2010 |
Khanna KM, Blair DA, Vella AT, McSorley SJ, Datta SK, Lefrançois L. T cell and APC dynamics in situ control the outcome of vaccination. Journal of Immunology (Baltimore, Md. : 1950). 185: 239-52. PMID 20530268 DOI: 10.4049/Jimmunol.0901047 |
0.463 |
|
| 2010 |
Zhang B, Zhang Y, Niu L, Vella AT, Mittler RS. Dendritic cells and Stat3 are essential for CD137-induced CD8 T cell activation-induced cell death. Journal of Immunology (Baltimore, Md. : 1950). 184: 4770-8. PMID 20351189 DOI: 10.4049/Jimmunol.0902713 |
0.495 |
|
| 2010 |
McAleer JP, Liu B, Li Z, Ngoi SM, Dai J, Oft M, Vella AT. Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization. Journal of Leukocyte Biology. 88: 21-31. PMID 20130220 DOI: 10.1189/Jlb.0909631 |
0.428 |
|
| 2009 |
Ménoret A, McAleer JP, Ngoi SM, Ray S, Eddy NA, Fenteany G, Lee SJ, Rossi RJ, Mukherji B, Allen DL, Chakraborty NG, Vella AT. The oxazolidinone derivative locostatin induces cytokine appeasement. Journal of Immunology (Baltimore, Md. : 1950). 183: 7489-96. PMID 19917702 DOI: 10.4049/Jimmunol.0901414 |
0.437 |
|
| 2009 |
McAleer JP, Rossi RJ, Vella AT. Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF. Journal of Immunology (Baltimore, Md. : 1950). 182: 5322-30. PMID 19380779 DOI: 10.4049/Jimmunol.0803616 |
0.529 |
|
| 2009 |
Lee SJ, Long M, Adler AJ, Mittler RS, Vella AT. The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death. Journal of Leukocyte Biology. 85: 175-85. PMID 18923104 DOI: 10.1189/Jlb.0408248 |
0.476 |
|
| 2008 |
McAleer JP, Vella AT. Understanding how lipopolysaccharide impacts CD4 T-cell immunity. Critical Reviews in Immunology. 28: 281-99. PMID 19166381 DOI: 10.1615/Critrevimmunol.V28.I4.20 |
0.489 |
|
| 2008 |
Bandyopadhyay S, Long M, Qui HZ, Hagymasi AT, Slaiby AM, Mihalyo MA, Aguila HL, Mittler RS, Vella AT, Adler AJ. Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation. Journal of Immunology (Baltimore, Md. : 1950). 181: 7728-37. PMID 19017962 DOI: 10.4049/Jimmunol.181.11.7728 |
0.431 |
|
| 2008 |
Ngoi SM, Tovey MG, Vella AT. Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta. Journal of Immunology (Baltimore, Md. : 1950). 181: 7670-80. PMID 19017955 DOI: 10.4049/Jimmunol.181.11.7670 |
0.494 |
|
| 2008 |
Muralimohan G, Rossi RJ, Guernsey LA, Thrall RS, Vella AT. Inhalation of Staphylococcus aureus enterotoxin A induces IFN-gamma and CD8 T cell-dependent airway and interstitial lung pathology in mice. Journal of Immunology (Baltimore, Md. : 1950). 181: 3698-705. PMID 18714046 DOI: 10.4049/Jimmunol.181.5.3698 |
0.449 |
|
| 2008 |
Muralimohan G, Rossi RJ, Vella AT. Recruitment and in situ renewal regulate rapid accumulation of CD11c+ cells in the lung following intranasal superantigen challenge. International Archives of Allergy and Immunology. 147: 59-73. PMID 18451649 DOI: 10.1159/000128660 |
0.368 |
|
| 2008 |
Carson WF, Guernsey LA, Singh A, Vella AT, Schramm CM, Thrall RS. Accumulation of regulatory T cells in local draining lymph nodes of the lung correlates with spontaneous resolution of chronic asthma in a murine model. International Archives of Allergy and Immunology. 145: 231-43. PMID 17914275 DOI: 10.1159/000109292 |
0.306 |
|
| 2007 |
Ramesh M, Turner LF, Yadav R, Rajan TV, Vella AT, Kuhn LT. Effects of the physico-chemical nature of two biomimetic crystals on the innate immune response. International Immunopharmacology. 7: 1617-29. PMID 17996671 DOI: 10.1016/J.Intimp.2007.08.011 |
0.358 |
|
| 2007 |
McAleer JP, Zammit DJ, Lefrançois L, Rossi RJ, Vella AT. The lipopolysaccharide adjuvant effect on T cells relies on nonoverlapping contributions from the MyD88 pathway and CD11c+ cells. Journal of Immunology (Baltimore, Md. : 1950). 179: 6524-35. PMID 17982041 DOI: 10.4049/Jimmunol.179.10.6524 |
0.487 |
|
| 2007 |
Salazar-Gonzalez RM, Srinivasan A, Griffin A, Muralimohan G, Ertelt JM, Ravindran R, Vella AT, McSorley SJ. Salmonella flagellin induces bystander activation of splenic dendritic cells and hinders bacterial replication in vivo. Journal of Immunology (Baltimore, Md. : 1950). 179: 6169-75. PMID 17947692 DOI: 10.4049/Jimmunol.179.9.6169 |
0.46 |
|
| 2007 |
Long M, Slaiby AM, Wu S, Hagymasi AT, Mihalyo MA, Bandyopadhyay S, Vella AT, Adler AJ. Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigen. Journal of Immunology (Baltimore, Md. : 1950). 179: 5669-77. PMID 17947638 DOI: 10.4049/Jimmunol.179.9.5669 |
0.452 |
|
| 2007 |
Müller-Doblies UU, Maxwell SS, Boppana VD, Mihalyo MA, McSorley SJ, Vella AT, Adler AJ, Wikel SK. Feeding by the tick, Ixodes scapularis, causes CD4(+) T cells responding to cognate antigen to develop the capacity to express IL-4. Parasite Immunology. 29: 485-99. PMID 17883452 DOI: 10.1111/J.1365-3024.2007.00966.X |
0.468 |
|
| 2007 |
Zhang B, Maris CH, Foell J, Whitmire J, Niu L, Song J, Kwon BS, Vella AT, Ahmed R, Jacob J, Mittler RS. Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent. The Journal of Clinical Investigation. 117: 3029-41. PMID 17853940 DOI: 10.1172/Jci32426 |
0.493 |
|
| 2007 |
Lee SJ, Rossi RJ, Lee SK, Croft M, Kwon BS, Mittler RS, Vella AT. CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent. Journal of Immunology (Baltimore, Md. : 1950). 179: 2203-14. PMID 17675480 DOI: 10.4049/Jimmunol.179.4.2203 |
0.468 |
|
| 2007 |
Niu L, Strahotin S, Hewes B, Zhang B, Zhang Y, Archer D, Spencer T, Dillehay D, Kwon B, Chen L, Vella AT, Mittler RS. Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice. Journal of Immunology (Baltimore, Md. : 1950). 178: 4194-213. PMID 17371976 DOI: 10.4049/Jimmunol.178.7.4194 |
0.507 |
|
| 2007 |
Dai J, Liu B, Ngoi SM, Sun S, Vella AT, Li Z. TLR4 hyperresponsiveness via cell surface expression of heat shock protein gp96 potentiates suppressive function of regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 178: 3219-25. PMID 17312170 DOI: 10.4049/Jimmunol.178.5.3219 |
0.462 |
|
| 2007 |
Cone RE, Li X, Sharafieh R, O'Rourke J, Vella AT. The suppression of delayed-type hypersensitivity by CD8+ regulatory T cells requires interferon-gamma. Immunology. 120: 112-9. PMID 17052246 DOI: 10.1111/j.1365-2567.2006.02486.x |
0.427 |
|
| 2006 |
Ménoret A, Myers LM, Lee SJ, Mittler RS, Rossi RJ, Vella AT. TGFbeta protein processing and activity through TCR triggering of primary CD8+ T regulatory cells. Journal of Immunology (Baltimore, Md. : 1950). 177: 6091-7. PMID 17056535 DOI: 10.4049/Jimmunol.177.9.6091 |
0.477 |
|
| 2006 |
Muralimohan G, Vella AT. A role for IFNgamma in differential superantigen stimulation of conventional versus plasmacytoid DCs. Cellular Immunology. 242: 9-22. PMID 17045255 DOI: 10.1016/J.Cellimm.2006.08.007 |
0.505 |
|
| 2006 |
Yadav R, Zammit DJ, Lefrancois L, Vella AT. Effects of LPS-mediated bystander activation in the innate immune system. Journal of Leukocyte Biology. 80: 1251-61. PMID 16973890 DOI: 10.1189/Jlb.0406253 |
0.396 |
|
| 2006 |
Maxwell JR, Yadav R, Rossi RJ, Ruby CE, Weinberg AD, Aguila HL, Vella AT. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. Journal of Immunology (Baltimore, Md. : 1950). 177: 234-45. PMID 16785519 DOI: 10.4049/Jimmunol.177.1.234 |
0.465 |
|
| 2006 |
Salazar-Gonzalez RM, Niess JH, Zammit DJ, Ravindran R, Srinivasan A, Maxwell JR, Stoklasek T, Yadav R, Williams IR, Gu X, McCormick BA, Pazos MA, Vella AT, Lefrancois L, Reinecker HC, et al. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity. 24: 623-32. PMID 16713979 DOI: 10.1016/J.Immuni.2006.02.015 |
0.443 |
|
| 2006 |
Myers L, Lee SW, Rossi RJ, Lefrancois L, Kwon BS, Mittler RS, Croft M, Vella AT. Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cells. International Immunology. 18: 325-33. PMID 16373363 DOI: 10.1093/Intimm/Dxh371 |
0.474 |
|
| 2005 |
Myers LM, Vella AT. Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation Trends in Immunology. 26: 440-446. PMID 15979409 DOI: 10.1016/J.It.2005.06.003 |
0.491 |
|
| 2005 |
Myers L, Croft M, Kwon BS, Mittler RS, Vella AT. Peptide-specific CD8 T regulatory cells use IFN-gamma to elaborate TGF-beta-based suppression. Journal of Immunology (Baltimore, Md. : 1950). 174: 7625-32. PMID 15944263 DOI: 10.4049/Jimmunol.174.12.7625 |
0.459 |
|
| 2005 |
Lee SW, Vella AT, Kwon BS, Croft M. Enhanced CD4 T cell responsiveness in the absence of 4-1BB. Journal of Immunology (Baltimore, Md. : 1950). 174: 6803-8. PMID 15905521 DOI: 10.4049/Jimmunol.174.11.6803 |
0.509 |
|
| 2004 |
Rossi RJ, Muralimohan G, Maxwell JR, Vella AT. Staphylococcal enterotoxins condition cells of the innate immune system for Toll-like receptor 4 stimulation. International Immunology. 16: 1751-60. PMID 15504761 DOI: 10.1093/Intimm/Dxh176 |
0.37 |
|
| 2004 |
Lee SJ, Myers L, Muralimohan G, Dai J, Qiao Y, Li Z, Mittler RS, Vella AT. 4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function. Journal of Immunology (Baltimore, Md. : 1950). 173: 3002-12. PMID 15322159 DOI: 10.4049/Jimmunol.173.5.3002 |
0.508 |
|
| 2004 |
Maxwell JR, Rossi RJ, McSorley SJ, Vella AT. T cell clonal conditioning: a phase occurring early after antigen presentation but before clonal expansion is impacted by Toll-like receptor stimulation. Journal of Immunology (Baltimore, Md. : 1950). 172: 248-59. PMID 14688332 DOI: 10.4049/Jimmunol.172.1.248 |
0.468 |
|
| 2003 |
Milston RH, Vella AT, Crippen TL, Fitzpatrick MS, Leong JA, Schreck CB. In vitro detection of functional humoral immunocompetence in juvenile chinook salmon (Oncorhynchus tshawytscha) using flow cytometry. Fish & Shellfish Immunology. 15: 145-58. PMID 12834618 DOI: 10.1016/S1050-4648(02)00151-1 |
0.318 |
|
| 2003 |
Myers L, Takahashi C, Mittler RS, Rossi RJ, Vella AT. Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering. Proceedings of the National Academy of Sciences of the United States of America. 100: 5348-53. PMID 12695569 DOI: 10.1073/Pnas.0837611100 |
0.517 |
|
| 2002 |
Byrd CM, Bolken TC, Jones KF, Warren TK, Vella AT, McDonald J, King D, Blackwood Z, Hruby DE. Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectors. Vaccine. 20: 2197-205. PMID 12009273 DOI: 10.1016/S0264-410X(02)00144-5 |
0.34 |
|
| 2002 |
Maxwell JR, Ruby C, Kerkvliet NI, Vella AT. Contrasting the roles of costimulation and the natural adjuvant lipopolysaccharide during the induction of T cell immunity. Journal of Immunology (Baltimore, Md. : 1950). 168: 4372-81. PMID 11970979 DOI: 10.4049/Jimmunol.168.9.4372 |
0.487 |
|
| 2001 |
Weatherill AR, Maxwell JR, Takahashi C, Weinberg AD, Vella AT. OX40 ligation enhances cell cycle turnover of Ag-activated CD4 T cells in vivo. Cellular Immunology. 209: 63-75. PMID 11414737 DOI: 10.1006/Cimm.2001.1783 |
0.464 |
|
| 2001 |
Takahashi C, Mittler RS, Vella AT. Differential clonal expansion of CD4 and CD8 T cells in response to 4-1BB ligation: Contribution of 4-1BB during inflammatory responses Immunology Letters. 76: 183-191. PMID 11306146 DOI: 10.1016/S0165-2478(01)00188-2 |
0.504 |
|
| 2001 |
Vella AT. Uncovering the Differences between T Cell Tolerance and Immunity Archivum Immunologiae Et Therapiae Experimentalis. 48: 331-338. DOI: 10.1007/978-94-010-0981-2_2 |
0.441 |
|
| 2000 |
Prell RA, Dearstyne E, Steppan LG, Vella AT, Kerkvliet NI. CTL hyporesponsiveness induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin: Role of cytokines and apoptosis Toxicology and Applied Pharmacology. 166: 214-221. PMID 10906285 DOI: 10.1006/Taap.2000.8971 |
0.456 |
|
| 2000 |
Maxwell JR, Weinberg A, Prell RA, Vella AT. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion Journal of Immunology. 164: 107-112. PMID 10605000 DOI: 10.4049/Jimmunol.164.1.107 |
0.466 |
|
| 1999 |
Hamelmann E, Takeda K, Schwarze J, Vella AT, Irvin CG, Gelfand EW. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. American Journal of Respiratory Cell and Molecular Biology. 21: 480-489. PMID 10502558 DOI: 10.1165/Ajrcmb.21.4.3659 |
0.357 |
|
| 1999 |
Campbell JD, Cole M, Bunditrutavorn B, Vella AT. Ascorbic acid is a potent inhibitor of various forms of T cell apoptosis. Cellular Immunology. 194: 1-5. PMID 10357874 DOI: 10.1006/Cimm.1999.1485 |
0.387 |
|
| 1998 |
Weinberg AD, Vella AT, Croft M. OX-40: life beyond the effector T cell stage. Seminars in Immunology. 10: 471-480. PMID 9826580 DOI: 10.1006/Smim.1998.0146 |
0.488 |
|
| 1998 |
Vella AT, Dow S, Potter TA, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 95: 3810-5. PMID 9520449 DOI: 10.1073/Pnas.95.7.3810 |
0.404 |
|
| 1997 |
Vella A, Teague TK, Ihle J, Kappler J, Marrack P. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. The Journal of Experimental Medicine. 186: 325-30. PMID 9221762 DOI: 10.1084/Jem.186.2.325 |
0.416 |
|
| 1997 |
Hamelmann E, Vella AT, Oshiba A, Kappler JW, Marrack P, Gelfand EW. Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 94: 1350-5. PMID 9037056 DOI: 10.1073/Pnas.94.4.1350 |
0.392 |
|
| 1996 |
Vella AT, Scherer MT, Schultz LD, Kappler JW, Marrack P. B cells are not essential for peripheral T-cell tolerance Proceedings of the National Academy of Sciences of the United States of America. 93: 951-955. PMID 8570666 DOI: 10.1073/Pnas.93.2.951 |
0.448 |
|
| 1995 |
Humphries D, Vella AT, Pearce EJ. Increased CD4+ T cell-dependent anti-erythrocyte antibody levels following the onset of parasite egg production in Schistosoma mansoni infected mice. Parasite Immunology. 16: 469-77. PMID 7838596 DOI: 10.1111/J.1365-3024.1994.Tb00375.X |
0.325 |
|
| 1995 |
Vella AT, McCormack JE, Linsley PS, Kappler JW, Marrack P. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity. 2: 261-70. PMID 7535182 DOI: 10.1016/1074-7613(95)90050-0 |
0.451 |
|
| 1993 |
Vella AT, Pearce EJ. CD4+ T-cell receptor Vβ usage during the immune response to Schistosoma mansoni Infection and Immunity. 61: 5381-5383. PMID 7901168 DOI: 10.1128/Iai.61.12.5381-5383.1993 |
0.478 |
|
| Show low-probability matches. |